(VYNE) – Momentum Movers
-
VYNE Therapeutics (VYNE) Announces Positive Preclinical Data for Inhaled Formulation of VYN201 in an In Vivo Model of Idiopathic Pulmonary Fibrosis
-
VYNE Therapeutics (VYNE) and Ardelyx (ARDX) Top Cantor Fitzgerald's Most Shorted Biotech List
Back to VYNE Stock Lookup